Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

CytoTools AG

Start price
Target price
Perf. (%)
€1.15
28.11.22
-
28.11.23
91.30%
24.04.23

Probably not worthwhile Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.13
28.11.22
-
28.11.23
-1.66%
10.12.22

Risky Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.13
28.11.22
-
28.11.23
-3.64%
12.12.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.33
27.11.22
-
27.11.23
-14.77%
11.12.22

Risky Investment
buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.72
22.11.22
-
22.11.23
-66.14%
23.11.23

Could be worthwhile Investment >10% per year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.58
21.11.22
-
21.11.23
-85.09%
22.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.34
19.11.22
€0.10
19.11.23
-5.60%
27.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
19.11.22
€2.00
19.11.23
-41.00%
20.11.23

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.63
19.11.22
€2.50
19.11.23
-46.91%
11.03.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.85
17.11.22
-
17.11.23
-17.52%
27.11.22

Risky Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.62
16.11.22
€1.00
16.11.23
26.73%
23.01.23

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€6.75
14.11.22
€10.00
14.11.23
31.66%
17.11.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.80
14.11.22
-
14.11.23
-13.88%
28.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€7.15
13.11.22
-
13.11.23
-20.98%
26.11.22

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€19.00
12.11.22
€25.00
12.11.23
-7.37%
12.11.23

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Innovative
Some uniques
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.96
12.11.22
€0.000
12.11.23
-17.89%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€124.30
11.11.22
€165.00
08.09.26
32.37%
30.08.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.37
10.11.22
€70.00
10.11.25
-39.33%
30.08.24

buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.91
08.11.22
€4.20
08.11.23
23.85%
16.11.22

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€100.60
08.11.22
€150.00
31.01.25
5.77%
05.05.23

Could be worthwhile Investment >10% per year
buy
Syneos Health, Inc.

Start price
Target price
Perf. (%)
€26.12
04.11.22
-
04.11.23
23.91%
10.11.22

Risky Investment
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€38.20
04.11.22
€32.00
31.12.24
6.81%
21.12.22

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.62
03.11.22
-
03.11.23
13.26%
10.11.22

Could be very worthwhile Investment >20% year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€758.30
01.11.22
€900.00
01.11.23
-9.34%
05.05.23

Could be very worthwhile Investment >20% year